Male hormones (called androgens), particularly testosterone and dihydrotestosterone, determine male secondary sex characteristics and stimulate prostate cell growth. When prostate cells, both healthy and cancerous, are deprived of androgens, they no longer proliferate and eventually die.
Hormonal treatment in prostate cancer uses drugs or surgery (orchiectomy) to suppress or block male hormones (androgen), particularly testosterone and...
Read moreProstate cancer is a hormonally responsive cancer. In 1966, Charles Huggins was awarded the Nobel Prize in Physiology or Medicine for... Read more »
Medical therapy to induce a castration is generally intended for use in patients who have advanced disease not curable by surgery,... Read more »
Men who receive hormone therapy for prostate cancer may be at greater risk for heart disease, but some types of therapy are safer than others,... Read more »
Source: National Cancer Institute
Colorectal Cancer Research from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: NCI Fact Sheet Key Points • • • The... Read more »
Source: ADAM Encyclopedia
About 12% of women will develop invasive breast cancer in their lifetime. Each year in the United States, about 207,000 women are diagnosed with... Read more »
Researchers say that up to 69 percent of men who receive androgen deprivation therapy (ADT) to treat prostate cancer may experience some form of... Read more »
(Ivanhoe Newswire) New research reveals prostate tumors produce their own testosterone, causing prostate cancer to spread. In research based on... Read more »